“Chemo Brain”—Is Cancer Survivorship Related to Later-Life Cognition? Findings From the Health and Retirement Study

Abstract

Objective: Studies have shown a correlation between cancer and cognition referred to as “chemo brain.” This study investigated the relationship between cancer and later-life cognition using nationally representative data. Method: Analysis of the 2006 Health and Retirement Study investigated the (a) effects of cancer survivorship on the total cognition score using linear regression in adults age 65+ (n = 9,814) and (b) the effects of cancer treatment on the total recall index using linear regression in adults age 50+ (n = 657). Results: Total cognition score is not associated with cancer survivorship. The association between long-term cancer survivorship and cognition score was significant (p < .05; b = .276). Total recall index is not associated with chemotherapy. Discussion: These results support other research suggesting that chemo brain may be biased by expectation as well as favored by research that relies upon self-reported cognitive measures versus cognitive testing. The study was limited by the cross-sectional design.

Keywords

cancer cognitive function cognitive status geriatrics

Get full access to this article

View all access options for this article.

References

Anstey

Christensen

(2000). Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: A review. Gerontology, 46, 163-177.

Barnes

D. E.

Alexopoulos

G. S.

Lopez

O. L.

Williamson

J. D.

Yaffe

(2006). Depressive symptoms, vascular disease, and mild cognitive impairment: Findings from the cardiovascular health study. Archives of General Psychiatry, 63, 273-279.

Bellizzi

K. M.

Mustian

K. M.

Palesh

O. G.

Diefenbach

(2008). Cancer survivorship and aging: Moving the science forward. Cancer, 113(12 Suppl.), 3530-3539.

Bellury

L. M.

Ellington

Beck

S. L.

Stein

Pett

Clark

(2011). Elderly cancer survivorship: An integrative review and conceptual framework. European Journal of Oncology Nursing, 15, 233-242.

Centers for Disease Control and Prevention. (2011). Assessing your weight. Retrieved from http://www.cdc.gov/healthyweight/assessing/index.html

Chodosh

Kado

D. M.

Seeman

T. E.

Karlamangla

A. S.

(2007). Depressive symptoms as a predictor of cognitive decline: MacArthur studies of successful aging. American Journal of Geriatric Psychiatry, 15, 406-415.

Coyne

B. M.

Leslie

M. L.

(2004). Chemo’s toll on memory. RN, 67(4), 40-43.

Cull

Gregor

Hopwood

Macbeth

Karnicka-Mlodkowska

Thatcher

Stewart

(1994). Neurological and cognitive impairment in long-term survivors of small cell lung cancer. European Journal of Cancer, 30, 1067-1074.

de Ruiter

M. B.

Reneman

Boogerd

Veltman

D. J.

van Dam

F. S.

Nederveen

A. J.

Schagen

S. B.

(2011). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32, 1206-1219.

10.

Elias

Sullivan

Wolf

D’Agostino

(2003). Lower cognitive function in the presence of obesity and hypertension: The Framingham heart study. International Journal of Obesity, 27, 260-268.

11.

Falleti

M. G.

Sanfilippo

Maruff

Weih

L. A.

Phillips

K. A.

(2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain and Cognition, 59, 60-70.

12.

Ferguson

R. J.

McDonald

B. C.

Saykin

A. J.

Ahles

T. A.

(2007). Brain structure and function differences in monozygotic twins: Possible effects of breast cancer chemotherapy. Journal of Clinical Oncology, 25, 3866-3870.

13.

Gan

H. K.

Bernstein

L. J.

Brown

Ringash

Vakilha

Wang

O’Sullivan

(2011). Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer. International Journal of Radiation Oncology Biology Physics, 81, 126-134.

14.

Goodwin

J. S.

Samet

J. M.

Hunt

W. C.

(1996). Determinants of survival in older cancer patients. Journal of the National Cancer Institute, 88, 1031-1038.

15.

Grova

E. K.

Fosså

S. D.

Dahl

A. A.

(2011). Short-term and long-term elderly cancer survivors: A population-based comparative and controlled study of morbidity, psychosocial situation, and lifestyle. European Journal of Oncology Nursing, 15, 213-220. doi:10.1016/j.ejon.2010.06.011

16.

Heflin

L. H.

Meyerowitz

B. E.

Hall

Lichtenstein

Johansson

Pedersen

N. L.

Gatz

(2005). Cancer as a risk factor for long-term cognitive deficits and dementia. Journal of the National Cancer Institute, 97, 854-856.

17.

Howlader

Noone

A. M.

Krapcho

Neyman

Aminou

Waldron

Edwards

B. K.

(Eds.). (2011). SEER Cancer Statistics Review, 1975–2008. Bethesda, MD: National Cancer Institute. Retrieved from http://seer.cancer.gov/csr/1975_2008/

18.

Jansen

C. E.

Cooper

B. A.

Dodd

M. J.

Miaskowski

C. A.

(2011). A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Supportive Care in Cancer, 19, 1647-4656.

19.

Jansen

C. E.

Miaskowski

Dodd

Dowling

Kramer

(2005). A meta-analysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer, 104, 2222-2233.

20.

Jenkins

Ofstedal

Weir

(2008). Documentation of health behaviors and risk factors measured in the health and retirement study (HRS/AHEAD). Retrieved from http://hrsonline.isr.umich.edu/sitedocs/userg/dr-010.pdf

21.

Keating

N. L.

Nørredam

Landrum

M. B.

Huskamp

H. A.

Meara

(2005). Physical and mental health status of older long-term cancer survivors. Journal of the American Geriatrics Society, 53, 2145-2152.

22.

Kurita

Meyerowitz

B. E.

Hall

Gatz

(2011). Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatment. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 66A, 1343-1349.

23.

Lachman

Spiro

(2002). Critique of cognitive measures in the health retirement study (HRS) and the asset and health dynamics among the oldest old (AHEAD) study. Retrieved from http://hrsonline.isr.umich.edu/sitedocs/dmc/Lachman_hrscognitive.pdf

24.

Luchsinger

J. A.

Reitz

Patel

Tang

M. X.

Manly

J. J.

Mayeux

(2007). Relation of diabetes to mild cognitive impairment. Archives of Neurology, 64, 570-575.

25.

Luo

Waite

L. J.

(2005). The impact of childhood and adult SES on physical, mental, and cognitive well-being in later life. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 60(Special Issue 2), S93.

26.

Minisini

Atalay

Bottomley

Puglisi

Piccart

Biganzoli

(2004). What is the effect of systemic anticancer treatment on cognitive function? The Lancet Oncology, 5, 273-282.

27.

Moorhouse

Rockwood

(2008). Vascular cognitive impairment: Current concepts and clinical developments. The Lancet Neurology, 7, 246-255.

28.

National Cancer Institute. (2011). National institutes of health (NIH), dictionary of cancer terms. Retrieved from http://www.cancer.gov/dictionary

29.

Ofstedal

Fisher

Herzog

(2005). Documentation of cognitive functioning measures in the health and retirement study. Retrieved from http://hrsonline.isr.umich.edu/sitedocs/userg/dr-006.pdf

30.

Okereke

O. I.

Kang

J. H.

Cook

N. R.

Gaziano

J. M.

Manson

J. A. E.

Buring

J. E.

Grodstein

(2008). Type 2 diabetes mellitus and cognitive decline in two large cohorts of community-dwelling older adults. Journal of the American Geriatrics Society, 56, 1028-1036.

31.

Rao

Demark-Wahnefried

(2006). The older cancer survivor. Critical Reviews in Oncology/Hematology, 60, 131-143.

32.

Reitz

Tang

M. X.

Manly

Mayeux

Luchsinger

J. A.

(2007). Hypertension and the risk of mild cognitive impairment. Archives of Neurology, 64, 1734-1740.

33.

Serrano

Domingo

Rodríguez-Garcia

Castro

M. D.

del Ser

(2007). Frequency of cognitive impairment without dementia in patients with stroke. Stroke, 38, 105-110.

34.

Servais

(2010). Overview of HRS public data files for cross-sectional and longitudinal analysis (Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor). Retrieved from http://hrsonline.isr.umich.edu/sitedocs/dmgt/-OverviewofHRSPublicData.pdf

35.

Skaali

Fosså

S. D.

Dahl

A. A.

(2011). A prospective study of cognitive complaints in patients with testicular cancer. Clinical Genitourinary Cancer, 9, 6-13.

36.

Staat

Segatore

(2005). The phenomenon of chemo brain. Clinical Journal of Oncology Nursing, 9, 713-721.

37.

St. Clair

Blake

Bugliari

Campbell

Chien

Zissimopoulus

(2011). RAND HRS Data Documentation, Version L. Retrieved from http://hrsonline.isr.umich.edu/modules/meta/rand/randhrsl/randhrsL.pdf

38.

Tervo

Kivjpetto

Hanninen

Vanhanen

Hallikainen

Mannermaa

Soininen

(2004). Incidence and risk factors for mild cognitive impairment: A population-based three-year follow-up study of cognitively healthy elderly subjects. Dementia and Geriatric Cognitive Disorders, 17, 196-203.

39.

van Gelder

B. M.

Tijhuis

Kalmijn

Giampaoli

Nissinen

Kromhout

(2006). Marital status and living situation during a 5-year period are associated with a subsequent 10-year cognitive decline in older men: The FINE study. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 61, 213-219.

40.

Vardy

Wefel

Ahles

Tannock

Schagen

(2008). Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Annals of Oncology, 19(4), 623-629.

41.

Walsh

E. G.

Mitchell

J. B.

Berkmann

L. F.

(2003). Cognitive function and acute care utilization. The Journals of Gerontology Series B: Psychological Sciences and Social Sciences, 58, S38-S49.